CLINICAL TRIALS PROFILE FOR CEFTAZIDIME SODIUM
✉ Email this page to a colleague
All Clinical Trials for CEFTAZIDIME SODIUM
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00333385 ↗ | Continuous Versus Short Infusions of Ceftazidime in Cystic Fibrosis | Terminated | Baxter Healthcare Corporation | Phase 4 | 2001-10-01 | The aim of this trial was to compare the safety and efficacy of courses of tobramycin and ceftazidime, administered intravenously as either thrice daily short infusions or 24 h continuous infusion, in cystic fibrosis patients with acute exacerbation of chronic pulmonary PA infection. In conventional treatment regimens, ceftazidime is administered in the form of thrice daily short infusions, but pharmacodynamic considerations suggest that continuous infusion could be more effective. |
| NCT00333385 ↗ | Continuous Versus Short Infusions of Ceftazidime in Cystic Fibrosis | Terminated | GlaxoSmithKline | Phase 4 | 2001-10-01 | The aim of this trial was to compare the safety and efficacy of courses of tobramycin and ceftazidime, administered intravenously as either thrice daily short infusions or 24 h continuous infusion, in cystic fibrosis patients with acute exacerbation of chronic pulmonary PA infection. In conventional treatment regimens, ceftazidime is administered in the form of thrice daily short infusions, but pharmacodynamic considerations suggest that continuous infusion could be more effective. |
| NCT00333385 ↗ | Continuous Versus Short Infusions of Ceftazidime in Cystic Fibrosis | Terminated | Roche Pharma AG | Phase 4 | 2001-10-01 | The aim of this trial was to compare the safety and efficacy of courses of tobramycin and ceftazidime, administered intravenously as either thrice daily short infusions or 24 h continuous infusion, in cystic fibrosis patients with acute exacerbation of chronic pulmonary PA infection. In conventional treatment regimens, ceftazidime is administered in the form of thrice daily short infusions, but pharmacodynamic considerations suggest that continuous infusion could be more effective. |
| NCT00333385 ↗ | Continuous Versus Short Infusions of Ceftazidime in Cystic Fibrosis | Terminated | Vaincre la Mucoviscidose | Phase 4 | 2001-10-01 | The aim of this trial was to compare the safety and efficacy of courses of tobramycin and ceftazidime, administered intravenously as either thrice daily short infusions or 24 h continuous infusion, in cystic fibrosis patients with acute exacerbation of chronic pulmonary PA infection. In conventional treatment regimens, ceftazidime is administered in the form of thrice daily short infusions, but pharmacodynamic considerations suggest that continuous infusion could be more effective. |
| NCT00333385 ↗ | Continuous Versus Short Infusions of Ceftazidime in Cystic Fibrosis | Terminated | Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche | Phase 4 | 2001-10-01 | The aim of this trial was to compare the safety and efficacy of courses of tobramycin and ceftazidime, administered intravenously as either thrice daily short infusions or 24 h continuous infusion, in cystic fibrosis patients with acute exacerbation of chronic pulmonary PA infection. In conventional treatment regimens, ceftazidime is administered in the form of thrice daily short infusions, but pharmacodynamic considerations suggest that continuous infusion could be more effective. |
| NCT01601093 ↗ | Study on Ceftazidime and Sulbactam Sodium for Injection (2:1) for Treatment of Respiratory and Urinary Tract Infection | Suspended | Xiangbei Welman Pharmaceutical Co., Ltd | Phase 2 | 2011-11-01 | In the proposed study, the investigators plan to evaluate the efficacy and safety of Ceftazidime Sodium and Sulbactam Sodium for Injection(2:1) for the treatment of respiratory and urinary tract acute bacterial infection. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for CEFTAZIDIME SODIUM
Condition Name
Clinical Trial Locations for CEFTAZIDIME SODIUM
Clinical Trial Progress for CEFTAZIDIME SODIUM
Clinical Trial Phase
Clinical Trial Sponsors for CEFTAZIDIME SODIUM
Sponsor Name
